Incannex Healthcare Inc.

Nasdaq:IXHL

Pharmaceutical Preparations·NORWEST NSW

CEO

Latham Joel

CFO

Swan Joseph

Financials

9 shown

Type	Period	Ended	Filed
10-Q	Q4 2025	12/31/25	2/13/26	→
10-Q	Q3 2025	9/30/25	11/14/25	→
10-K	FY 2025	6/30/25	9/29/25	→
10-Q	Q1 2025	3/31/25	5/15/25	→
10-Q	Q4 2024	12/31/24	2/14/25	→
10-Q	Q3 2024	9/30/24	11/14/24	→
↓

News (8-K)

65 shown

Filed	Type	Description
2/25/26	Other	Material Modification to Rights of Security Holders	→
1/29/26	Other	Other Events	→
1/22/26	Other	Other Events	→
1/16/26	Vote	Submission of Matters to a Vote of Security Holders	→
1/15/26	Other	Other Events	→
1/14/26	Other	Other Events	→
↓

Prospectuses & Registrations

27 shown

Filed	Form	Description
11/14/25	S-8	REGISTRATION STATEMENT	→
10/27/25	ARS	FORM ARS	→
7/24/25	424B5	PROSPECTUS SUPPLEMENT	→
7/24/25	S-3MEF	REGISTRATION STATEMENT	→
6/4/25	S-8	REGISTRATION STATEMENT	→
5/28/25	424B5	PROSPECTUS SUPPLEMENT	→
↓

Filing History(243 filings)

TypeDateAccessionPeriodSize

8-K

Feb 25, 2026

0001213900-26-020127CURRENT REPORT

Feb 24, 2026

227.3 KB

10-Q

Feb 13, 2026

0001213900-26-015867QUARTERLY REPORT

Dec 31, 2025

3.8 MB

8-K

Jan 29, 2026

0001213900-26-009160CURRENT REPORT

Jan 29, 2026

220.4 KB

8-K

Jan 22, 2026

0001213900-26-006448CURRENT REPORT

Jan 22, 2026

235.5 KB

8-K

Jan 16, 2026

0001213900-26-004866CURRENT REPORT

Jan 15, 2026

193.7 KB

8-K

Jan 15, 2026

0001213900-26-004488CURRENT REPORT

Jan 15, 2026

217.5 KB

8-K

Jan 14, 2026

0001213900-26-004158CURRENT REPORT

Jan 14, 2026

243.1 KB

8-K

Dec 18, 2025

0001213900-25-123041CURRENT REPORT

Dec 18, 2025

188.5 KB

DEFA14A

Dec 18, 2025

0001213900-25-123039DEFINITIVE ADDITIONAL MATERIALS

—

14.5 KB

DEFA14A

Dec 16, 2025

0001213900-25-121876DEFINITIVE ADDITIONAL MATERIALS

—

14.8 KB

8-K

Dec 3, 2025

0001213900-25-117571CURRENT REPORT

Dec 3, 2025

215.1 KB

10-Q

Nov 14, 2025

0001213900-25-110299QUARTERLY REPORT

Sep 30, 2025

3.2 MB

Nov 14, 2025

0001213900-25-110290

Nov 14, 2025

8.9 KB

Nov 14, 2025

0001213900-25-110286

Nov 14, 2025

5.2 KB

Nov 14, 2025

0001213900-25-110284

Nov 14, 2025

5.2 KB

Nov 14, 2025

0001213900-25-110279

Nov 14, 2025

5.1 KB

Nov 14, 2025

0001213900-25-110275

Nov 14, 2025

5.2 KB

Nov 14, 2025

0001213900-25-110271

Nov 14, 2025

5.3 KB

S-8

Nov 14, 2025

0001213900-25-110267REGISTRATION STATEMENT

—

191.6 KB

8-K

Oct 30, 2025

0001213900-25-103780CURRENT REPORT

Oct 30, 2025

227.4 KB

ARS

Oct 27, 2025

0001213900-25-102657FORM ARS

Jun 30, 2025

1.8 MB

DEFA14A

Oct 27, 2025

0001213900-25-102656DEFINITIVE ADDITIONAL MATERIALS

—

686.4 KB

DEF 14A

Oct 27, 2025

0001213900-25-102654DEFINITIVE PROXY STATEMENT

Dec 18, 2025

3.7 MB

8-K

Oct 22, 2025

0001213900-25-100985CURRENT REPORT

Oct 22, 2025

233.0 KB

8-K

Oct 22, 2025

0001213900-25-100980CURRENT REPORT

Oct 21, 2025

195.0 KB

25 filings shown

Filed	Form	Description
5/15/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
5/15/25	SCHEDULE 13G/A	SCHEDULE 13G/A	→
4/28/25	EFFECT	EFFECT	→
4/17/25	PRER14A	REVISED PRELIMINARY PROXY STATEMENT	→
3/17/25	D	D	→
3/14/25	SCHEDULE 13G	SCHEDULE 13G	→
↓

Incannex Healthcare Inc.

Financials

News (8-K)

Prospectuses & Registrations

Filing History(243 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
12/18/25	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
12/16/25	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
10/27/25	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
10/27/25	DEF 14A	DEFINITIVE PROXY STATEMENT	→
5/16/25	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
4/28/25	DEF 14A	DEF 14A	→
↓